glp-1 digital health news Shortage = Over Is Technology the Missing Piece
Description
But these studies examined substances one at a time
[DOI] [PMC free article] [PubMed] [Google Scholar] 47.Wang N., Zhou Y., Erasto Ngowi E., Qiao A
Emerging evidencestrengthened by ASCO GI 2026suggests that GLP-1 receptor agonists may define the next era by addressing the metabolic roots of colorectal carcinogenesis
The development of oral formulations, such as oral semaglutide, has been a notable advancement in improving treatment acceptance
XiaoTian L, QiNan W, XiaGuang G, WuQuan D, Bing C, ZiWen L
